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INTERAKSI NANOPARTIKEL BAHAN LEKAT SILIKA DAN 
BESI TEROKSIDA DENGAN SEL DENDRITIK DARIPADA SEL 
SUM-SUM TULANG TIKUS 
 
ABSTRAK 
 
Sel dendritik (SD) merupakan komponen penting imuniti semulajadi badan 
yang mana berfungsi untuk mengatur imuniti penyesuaian diri. SD bertindak sebagai 
kunci yang mengawal keseimbangan homeostasis imunisasi kita, sebagai sel 
pesembah antigen profesional, SD telah disasarkan dalam pelbagai aplikasi 
perubatan seperti di dalam penyelidikan vaksin dan pembangunan terapi imun 
berdasarkan kebolehan sel dendritik dalam memulakan imuniti semulajadi badan dan 
seterusnya mengaktifkan gerak balas imun perolehan. Kegunaan nanopartikel (NP) 
telah menunjukkan potensi yang hebat dalam mengaktifkan sel dendritik yang 
diperoleh daripada sum-sum tulang (SDST) mencit yang mengarah kepada 
kematangan SD, yang mana akan mendorong kepada tindakbalas imuniti semulajadi 
dan perolehan. Tujuan kajian ini adalah untuk menghasilkan dan mempercirikan dua 
jenis NP iaitu NP bahan lekat silika dan besi teroksida, untuk menentukan morfologi 
dan status keaktifan SDST apabila didedahkan kepada NP tersebut dan juga untuk 
memutuskan pengangkutan dan kemasukan kedua-dua NP ke dalam SDST. NP silika 
dan besi yang berbentuk sfera telahpun berjaya disintesis dan dicirikan dengan saiz 
hidrodinamik 174.7 nm ± 2.20 dan 214.0 nm ± 2.85, masing-masing. Kemudiannya, 
morfologi SD yang dihasilkan daripada sel sum-sum tulang mencit sebaik sahaja 
didedahkan kepada 25 ng/mL NP silika dan besi teroksida selama 24 jam telah 
xix 
 
diperhati melalui mikroskop imbasan elektron, yang mana mikroskop elektron 
berkenaan telah menunjukkan pengambilan NP ke dalam membran sel oleh SDST. 
Status pengaktifan SD setelah terdedah kepada NP silika dan besi teroksida telah 
ditentukan melalui analisis flow sitometri, yang mana keputusannya mendapati 
ekspresi penanda permukaan sel yakni; MHCII, CD86 dan CD11c bertambah bagi 
SDST yang terdedah kepada NP silika dan besi teroksida berbanding SDST yang 
tidak terdedah kepada mana-mana NP. Tambahan pula, kemasukan intrasel NP ke 
dalam SDST telah disahkan dengan mikroskop laser yang mendapati NP telah 
disimpan di dalam membran sel, membuktikan pengambilan NP oleh SDST. Selain 
itu, kadar kepekatan rembesan pro-radang IL-12p70 di dalam supernatan SDST yang 
terdedah kepada NP silika dan besi teroksida adalah lebih tinggi berbanding SDST 
yang tidak terdedah kepada mana-mana NP. Sementara penemuan-penemuan ini 
mededahkan beberapa aspek yang menjanjikan NP silika dan besi teroksida sebagai 
calon bagi aplikasi terapi yang berkesan pada masa depan, penemuan ini masih 
memerlukan banyak lagi penyelidikan sebelum boleh diintegrasikan ke dalam 
pembangunan agen penghantar ubatan, vaksin dan terapi imun pada masa depan. 
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INTERACTION OF SILICA COLLOID AND IRON OXIDE 
NANOPARTICLES WITH MICE BONE MARROW DERIVED-DENDRITIC 
CELLS 
 
ABSTRACT 
 
Dendritic cells (DCs) are an important component of innate immunity, which 
modulate the adaptive immunity. DCs act as a key sentinel in maintaining our 
immune homeostasis and as professional antigen-presenting cells (APCs). DCs have 
been targeted in various medical applications such as in vaccine research and 
immunotherapeutic development due to the ability of activated DCs in initiating the 
innate immune response and consequently trigger the adaptive immune response. 
The use of nanoparticles (NPs) have shown a great potential in activating bone 
marrow derived-dendritic cells (BMDCs) that lead to DCs maturation, which in turn 
will induce the innate and adaptive immune responses. The aims of this study is to 
produce and characterise two types of NPs namely silica colloid NPs and iron oxide 
NPs, to determine the morphology and activation status of BMDCs upon exposure to 
NPs and also to determine the uptake and intracellular localisation of both NPs by 
BMDCs. The spherical silica colloid and iron oxide NPs were successfully 
synthesised and characterised with the hydrodynamic size of 174.7 nm ± 2.20 and 
214.0 nm ± 2.85, respectively. Then, the morphology of generated DCs derived from 
the bone marrow stem cells of female BALB/c mice after 24 hours exposure to 25 
ng/mL silica colloid and iron oxide NPs were observed through a scanning electron 
microscope imaging, whereby the electron microscopy showed that the BMDCs 
internalised the NPs into their enclosed membrane. The activation status of BMDCs 
xxi 
 
upon exposure to silica colloid and iron oxide NPs were determined through flow 
cytometry analyses, in which the expression of DCs surface markers; MHCII, CD86 
and CD11c were enhanced in the BMDCs that were exposed to the silica colloid and 
iron oxide NPs as compared to the BMDCs without NPs exposure. Furthermore, the 
intracellular localisation of NPs into BMDCs was confirmed by confocal laser 
scanning microscope, where NPs were deposited inside the membrane of the cells 
indicating the uptake of NPs into the BMDCs. Besides, the concentration of pro-
inflammatory cytokine IL-12p70 in the cell culture supernatant of BMDCs exposed 
to silica colloid and iron oxide NPs were higher than the BMDCs that do not 
exposed to NPs. Whilst these results revealed several promising aspect of the silica 
colloid and iron oxide NPs as a future candidate for an effective therapeutic 
applications, these findings warrant further research before they can be integrated 
into the development of future drug delivery agent, vaccine and immunotherapeutic 
treatments. 
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CHAPTER 1 
 
INTRODUCTION 
 
1.1 Human Immune System 
 
Human immune system made up of diverse plethora of cells, tissues and 
molecules that guarding and protecting the body against various microbes, 
pathogens, bacteria or viruses invasion. The word ‘immunity’ refers to the universal 
ability of the host (human immune system) to resist or either destroys the predation 
of microbes (Hoebe et al., 2004). The biggest dichotomy in immunity categorized 
into two general types of reactions which are an innate immunity and an adaptive 
immunity. These two general types of immunity are different in respect to the time 
taken for the immune response to occur, the period it takes to reacts against the 
pathogenic infection, the types of cells involved in each reaction and also the specific 
pathway mechanism for different classes of microbes. Despite the differences, both 
innate and adaptive immunity complement and rely on each other to maintain the 
balance of immune homeostasis. 
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1.1.1 Innate immunity 
 
Innate immunity is essential to induce protection against various pathogenic 
infections and it has been known as the first line of defence of immune system (Uto 
et al., 2009). The major components of the innate immunity are physical barriers 
(e.g. skin mucosal membrane of gastrointestinal tracts and respiratory tracts), 
phagocytic leukocytes (e.g. neutrophils, basophils, macrophages), antigen-presenting 
cells (APCs) such as dendritic cells (DCs), natural killer (NK) cells and plasma 
proteins. Innate immunity is a non-specific reaction that made up of those physical 
and chemical barriers that function to remove the pathogenic materials from the body 
or to limit the ability of the pathogen from spreading throughout the body. Besides, 
the innate immunity is activated immediately after recognizing the pathogen attacks 
and the release of their chemical properties. The innate immunity is important to 
induce the activation of consequent adaptive immunity. 
 
1.1.2 Adaptive immunity 
 
Other than the non-specific and natural innate immunity, adaptive immunity is 
known to be more specific and more potent in removing the invading pathogens (Uto 
et al., 2009). The adaptive immunity also called as an acquired immunity, gets into 
action towards the pathogens invasion that is capable to pass through the first line of 
defence which is the innate immunity. Unlike the mechanism of innate immunity 
that destroy the pathogens based on the general information of the pathogen threats, 
the adaptive immunity is initiated by the exposure to the pathogens and its develop 
an  immunological memory towards the threats and maintain the immune system 
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accordingly. The components of adaptive immunity comprises of the T lymphocytes 
and B lymphocytes that mediate a cell-mediated immunity and humoral immunity, 
respectively. 
 
B lymphocytes are derived; formed and matured in the bone marrow which 
contribute to its name “B lymphocytes” and migrate into the lymphatic system to 
circulate throughout the body. The cells mature while encountering an antigen and 
express membrane-bound antibodies on the cell surface. The mature B lymphocytes 
differentiated into either memory B lymphocytes or effector B lymphocytes (plasma 
cell). Both cells secrete a highly specific protein molecules or antibodies that identify 
any free pathogens roaming around in the body and bind to the specific antigen that 
present on the surface of infected cells or freely float in the cell’s body prior to the 
antigen destruction. The special ability of memory B lymphocytes assist the immune 
system to remember the disease and prevent re-infection in the future (Kurosaki et 
al., 2015). 
 
Another type of cellular components that made up the adaptive immunity is T 
lymphocytes. T lymphocytes are formed in the bone marrow, but it migrates to the 
thymus to mature and becoming T lymphocytes, thus the name. Instead of 
developing the expression of T-cell receptors (TCRs) to sense a specific protein 
sequence, T lymphocytes also express other receptors known as CD4 and CD8 
receptors. TCRs only recognise antigens that are attached to a certain membrane-
bound surface receptor on APCs, called as Major Histocompatibility Complex class 
1 (MHCI) and class 2 (MHCII). The naïve T lymphocytes undergo maturation upon 
encountering with antigens by the up-regulation of MHCI and MHCII, co-
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stimulatory molecules and adhesion molecules and differentiated into three types of 
mature T lymphocytes; CD4 helper T lymphocytes, CD8 cytotoxic T lymphocytes 
and regulatory T cells (Tregs). The CD4 activates B lymphocytes and attract APCs 
macrophages, the CD8 creates pores in the infected cells to trigger an apoptosis 
which in turn will eventually kill the infected host cells and Tregs reduce the 
possibility of autoimmune disease by helping the cells to distinguish between self 
and non-self molecule (Apostolou et al., 2002). 
 
As a whole, the response time of adaptive immunity is slower compared to the fast 
reaction of innate immunity but the specificity of adaptive immunity is highly 
specific and able to discriminate the differences between the pathogen and non-
pathogen molecular structures rather than only specific for molecular patterns of 
general pathogens as in innate immunity. Regardless of the advantages and 
disadvantages of both types of immunity, a proper consideration should be made in 
maintaining the innate and adaptive immunity as they depend heavily on each other. 
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1.2 Dendritic Cells 
 
1.2.1 Background and dendritic cells history 
 
Steinman and Cohn were the first who discovered DCs almost four decades 
ago. They found a group of cells in the spleen with unusual shapes and movements 
that differed from macrophages, with a tree-like stellate or ‘dendrites’ (Steinman and 
Cohn, 1973). Figure 1.1 shows cytoplasmic veils and dendrites protruding from the 
main body of DCs, which is prominent especially after antigen stimulation. DCs 
were later found to exist in lymphoid and non-lymphoid tissues. 
 
The successful generation of large numbers of DCs from CD34
+
 bone marrow 
precursor cells in early 1990s (Inaba et al., 1992a) and later from CD14
+
 monocytes 
(Silveira et al., 2013) allowed  more studies on DC properties and functions to be 
carried out. These include the interactions of DCs with other immune cells and the 
efficacy of  DC-based vaccines in pre-clinical and clinical aspects (Wieder, 2003) 
including cancer immunotherapy (Alamino et al., 2016; Dudek et al., 2013; Liu et 
al., 2015; Sánchez-Paulete et al., 2016; Sennikov et al., 2015), organ transplantation 
(Thomson et al., 2016) autoimmune diseases (Tian et al., 2016) and allergic diseases 
(Froidure et al., 2015). 
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Figure 1.1. The life cycle of DCs. Circulating immature DCs directly 
encounter pathogens and induce cytokines secretion, which in turn can 
activate other leukocytes e.g. eosinophils, NK cells and macrophages. After 
antigen capture, the immature DCs migrate to lymphoid organ and present 
the MHC-peptide to activate T lymphocytes. The activated T lymphocytes 
help terminal maturation of DCs that allows lymphocytes proliferation and 
differentiation. It will migrate and reach the injured tissue and produce a 
more potent immunological response. Hence, DCs are critical for the 
induction of immunological tolerance, as well as the regulation of T-cell 
mediated immune response (Banchereau et al., 2000). 
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1.2.2 Function and importance of dendritic cells 
 
To date, DCs have been proved to be one of the most essential cells that can 
initiate and modulate the immune response. The functions of DCs can be divided 
into three main categories: (1) antigen presentation and activation of T lymphocytes, 
(2) maintenance of immune tolerance and (3) maintenance of immunological 
memory of B lymphocytes, conducted by follicular DCs. 
 
Among these, the most prominent roles for DCs are the processing and presentation 
of antigens for the differentiation and activation of T lymphocytes. Immature DCs 
circulate throughout the peripheral lymphoid tissues to sample and capture foreign 
pathogens. The captured pathogens are internalized into specialized organelles, 
phagosomes and endosomes. When both compartments mature, they undergo 
molecular changes, for instance, fusion with other organelles that carry degrading 
enzymes as lysosomes. Then, antigenic peptides in the late lysosomes or endosomes 
can be generated and loaded onto MHCII molecules. The molecular complex is then 
transported to the cell surface for antigen presentation to T lymphocytes (Burgdorf 
and Kurts, 2008). The immature DCs become mature DCs during the process of 
capturing, processing and presenting the antigens (Lutz and Schuler, 2002). An 
adequate antigen presentation signal by DCs to T lymphocytes induces cytokine 
secretion and therefore activates effector T lymphocytes to get into action. 
  
After the thymic selection, the T lymphocytes undergo differentiation and divide into 
either effector T lymphocytes [e.g. helper T cells (CD4
+
), cytotoxic T cells (CD8
+
)], 
and Tregs. A recent study by Alamino et al. (2016) highlighted the importance of 
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enhancing the ability of DCs to stimulate the effector T lymphocytes, particularly 
cytotoxic T lymphocytes that have potential for DC-based immunotherapy (Alamino 
et al., 2016). Effector T lymphocytes and Tregs are part of cell-mediated immunity 
of adaptive immune response and play their own roles in the maintenance of the 
immune tolerance and protect the body against microbes. 
 
Besides activating immune response, DCs also play an important role in maintaining 
immunological tolerance (Wieder, 2003), which occurs in the thymus (central 
tolerance) and in the peripheral lymphoid organs (peripheral tolerance). In the 
thymic medulla, DCs present self-antigens in the context of MHC molecules and 
thymocytes with high affinity receptor to self-antigens are eliminated via negative 
selection, immunity elimination against ‘self’ due to their high affinity to self-
antigens. In the thymic cortex, macrophages digest the dying thymocytes which fail 
to go through positive selection. T lymphocytes should be tolerant to self-antigens 
prior to T lymphocyte activation in order to avoid the reactivation of auto-reactive T 
lymphocytes (Banchereau and Steinman, 1998). In addition, DCs also maintain 
peripheral tolerance through cytokines or cell-contact dependent mechanisms to 
prevent the induction of immune response on self-reactive T lymphocytes that 
escape the central tolerance (Mahnke et al., 2002). Therefore, immunological 
tolerance mediated by DCs is essential in protecting our immune system from 
autoimmune diseases since DCs might promote tolerance through generation and 
maintenance of Tregs as well as by the induction of T lymphocytes unresponsiveness 
(Ganguly et al., 2013).  
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Follicular dendritic cells (FDCs) are identified based on their specific morphology 
and the ability to capture immune-complexed antigens in B lymphocyte follicles in 
the germinal centers. FDCs directly sustain the viability, growth and differentiation 
of B lymphocytes (Banchereau and Steinman, 1998). FDCs recognise antigens by 
toll-like receptors (TLRs) and help in skewed B lymphocytes response and 
subsequently boosting adaptive immune responses (Aguzzi et al., 2014). Altogether, 
DCs are crucial in maintaining the immune homeostasis, directing T and B 
lymphocytes on one hand while upholding immunological tolerance on the other. 
 
1.2.3 Maturation of dendritic cells 
 
 As introduced earlier, DCs originated from the hematopoietic stem cells in 
the bone marrow and they are distributed within all lymphoid tissues as immature 
DCs. Immature DCs serve as a primary lineage of immune protection as they are 
recruited to the inflammatory sites in peripheral tissues after pathogen invasion. At 
this stage, the immature DCs internalize the pathogens via endocytosis pathways 
such as phagocytosis, pinocytosis, macropinocytosis (Kou et al., 2013) and receptor-
mediated endocytosis including caveolae- and clathrin-dependent and independent 
pathways (Pelkmans and Helenius, 2002). Immature DCs show high efficiency in the 
antigen uptake and processing which induce an incredible maturation process (Uto et 
al., 2009). 
 
The distinction between immature DCs and fully mature DCs are described based on 
phenotypic and functional changes (Dudek et al., 2013). While the immature DCs 
are becoming mature DCs, they undergo various changes that in turn, culminate in 
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the complete transition from antigen capturing cells to APCs. The DCs maturation 
process involves a redistribution of MHC molecules to the surface of DCs, 
morphological changes, increase in the surface expression of co-stimulatory and 
adhesion molecules, cytokines and proteases. The mature DCs that have undergone 
these dramatic changes have lost the ability to capture antigen, but they obtain 
another capacity, e.g. the presentation of antigen to T lymphocytes for the 
subsequent activation of T lymphocytes. 
 
Co-stimulatory molecules such as CD80, CD83, CD86, HLA-DR, IL-12 and CD40 
are upregulated in mature DCs, while the cytokine production of IL-10 is reduced 
(Daneshmandi et al., 2015; Liu et al., 2015). Large amounts of cytokines are 
produced by mature DCs that promote the recruitment of monocytes and 
upregulation of Chemokine (C-C Motif) Receptor 7 (CCR7). CCR7 is a chemokine 
receptor required for the migration of DCs into lymphatic vessels and their 
localisation to the T lymphocyte areas (Lanzavecchia and Sallusto, 2001). DCs then 
undergo the maturation process by upregulating T lymphocyte co-stimulatory 
molecules such as CD40, CD80, CD83 and CD86 (Cybulsky et al., 2016). T 
lymphocytes will bind to MHC antigen complexes and differentiate into CD4
+
 helper 
T cells, CD8
+
 cytotoxic T cells, Tregs and memory T cells. In response to multiple 
pathogens, T lymphocyte activation and differentiation lead to appropriate 
generation of responses either in the form of tolerance, memory and cytotoxicity in 
order to maintain the immunological homeostasis. 
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1.2.4 Uptake capacity of dendritic cells 
 
The initiation of immune responses can be described from the interaction of 
three immune parties that focused on antigens, lymphocytes and APCs which is, in 
this context are referring to DCs. DCs serve as the modulator and acts as a key 
sentinel in bridging both innate and adaptive immunity, where DCs capture and pass 
on the cellular information from the external environment to the adaptive immune 
cells (Banchereau et al., 2000; Banchereau and Steinman, 1998). DCs are important 
to induce the immunological tolerance as well as to regulate the T-lymphocytes 
mediated immune response (Banchereau et al., 2000). The uptake of intracellular or 
extracellular antigen by DCs is mediated by DCs uptake mechanisms, for example 
phagocytosis, macropinocytosis and receptor-mediated endocytosis (Figure 1.2). 
This antigen acquisition processes lead to presentation of the processed antigen 
peptides onto MHCI, MHCII and up-regulating the co-stimulatory molecules such as 
CD40, CD80 and CD86 to initiate the interaction with T lymphocytes of the adaptive 
immune system that consists of CD4
+
 helper T cells and CD8
+
 cytotoxic T cells 
phenotypes (Vallhov et al., 2007). 
 
Today’s advancement in medicine has provided an alternative to combat the 
drawbacks on the use of traditional drugs, have emerged plentifully by means of use 
of NPs that would improve the organ-targeting capacity especially in cancer patient, 
delivery of macro-molecules and minimizing the side effects of the traditional drugs 
(Moghimi et al., 2005). The NPs internalized by the APCs via endocytosis pathway 
that classified based on the type of proteins that play role in the endocytosis process. 
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One of the most important distinct mechanisms of antigen acquisition by the family 
of APCs which includes macrophages, neutrophils and DCs is phagocytosis process. 
Neutrophils rely on their response against invading microbes mechanism called as 
‘oxidative burst’, while macrophages depends on their lysosomal proteolytic activity 
to eliminate the phagocytosed pathogens which is critical in maintaining the safety 
environment in innate immune system. In comparison to both macrophages and 
neutrophils, DCs does not merely eliminate the pathogens but they also preserve any 
useful information from the internalized particles that will contribute their function 
in activating T lymphocytes and initiating the adaptive immune response.  
 
The cellular mechanism for phagocytic pathway for DCs starts with the recognition 
and uptake of pathogens, apoptotic cells or infected cells in the peripheral tissue and 
DCs process the antigens from these pathogenic cells into peptides form and load the 
peptides fragments on MHC class I or class II molecules. DCs then migrate to the 
secondary lymphoid organs to present the antigens to T lymphocytes recognition and 
activation that will initiate the adaptive immune response (Savina and Amigorena, 
2007). Phagocytosis process are mediated by several types of receptors such as Fc 
receptors, CD36 scavenger receptor, C-type lectins and complement receptors that 
recognise the ligands present on the pathogens and internalize them (Roche and 
Furuta, 2015).  
 
The DCs with high phagocytic activity usually performed by immature DCs that will 
develop into mature DCs upon encountering proinflammatory signals or TLRs 
ligands and subsequently loss their phagocytic activity due to the changes activity in 
Rac and Cdc42 (Nobes and Marsh, 2000). 
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Another endocytosis mechanism involved in the antigen acquisition of DCs is 
macropinocytosis, a non-specific uptake of solute or soluble molecules, nutrients and 
also antigens and often known as “cell-drinking” (Liu and Roche, 2015). 
Macropinocytosis is an actin-dependent formation that rise from the ruffles of 
plasma membrane forming a large vesicles called as macropinosomes that has a 
different forms compared to other endocytic vesicles (Liu and Roche, 2015; 
Norbury, 2006) with diameter size range of 0.2 up to 5 µm (Hewlett et al., 1994; 
Swanson and Watts, 1995). Macropinocytosis mediates the non-specific soluble 
antigen uptake into cellular compartment via the endocytic vesicles 
macropinosomes. The antigens that are enclosed within the macropinosomes are 
transferred into endosomal compartment that fuse with lysosomal compartment in 
order to process the antigen. After the antigen processing activity took place, the 
macropinocytosed antigens undergo degradation step and being loaded onto MHCII 
molecules (Liu and Roche, 2015). Since immature DCs can perform a great 
macropinocytosis activity, (Sallusto et al., 1995) found that the human monocyte 
derived-dendritic cells (MDDCs) cultured with GM-CSF and IL-4 can uptake the 
fluid-phase antigen for about 1 – 1.5 Pl and over 40 % of the cell volume per hour 
(Sallusto et al., 1995). In some extent, the mechanism of macropinocytosis and 
phagocytosis are quite similar in which upon stimulation with external stimuli that 
induce the maturation of DCs, the macropinocytosis process will be terminated and 
the process is irreversible. 
 
In addition to the non-specific antigen acquisition such as macropinocytosis, DCs 
also have several receptors on their cell surface that facilitates the uptake of antigen 
into the cellular processing compartment via a clathrin-mediated endocytosis 
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pathway. This receptor-mediated endocytosis bind the small soluble molecules 
antigen to a various types of receptors present on DCs such as Fc receptors, 
complement receptors and C-type lectins that will be internalized by either clathrin-
coated or non-clathrin-coated vesicles. Antigen captured in the clathrin-coated 
vesicles are send to endosomal compartment and to the antigen processing vesicle 
compartments for proteolytic enzyme degradation and for the formation of peptide 
loaded onto MHCII as to activate the resting T lymphocytes and to initiate the 
specific adaptive immune responses (Liu and Roche, 2015; Roche and Furuta, 2015). 
 
 
Figure 1.1.  Endocytosis of antigens in APCs that involve phagocytosis,   
macropinocytosis and clathrin-mediated endocytosis pathway (Roche and 
Furuta, 2015). 
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1.2.5 Bone marrow derived-dendritic cells 
 
Recently, DCs have been widely used as target cells for the production or 
induction of immunomodulatory and anti-inflammatory effects. Therefore, DCs are 
routinely cultured in vitro to assess their functions and actions (Inaba et al., 1990; 
Romani et al., 1989) and to determine basic pathophysiologic mechanism, to 
generate DC-based immunotherapy (Dudek et al., 2013) and to study their adjuvant 
properties (Romani et al., 1989; Steinman, 1991). 
 
The basic procedure to obtain bone marrow from femur of mice and to cultivate 
healthy bone marrow derived-dendritic cells (BMDCs) involves complex and 
multistep procedures (Madaan et al., 2014). BMDCs from mice and rats are cultured 
in vitro by using Growth Monocyte-Colony Stimulating Factor (GM-CSF) (Bowers 
and Berkowitz, 1986; Inaba et al., 1992a; Talmor et al., 1998). Lutz and colleagues 
have produced a 10-day procedure for generating BMDCs and have been widely 
used by researchers to generate DCs until now (Lutz et al., 1999).  
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1.3 Nanoparticles 
 
1.3.1 Definition and uses of nanoparticles 
 
In today modern world, nanoscience and nanotechnology have been regarded 
the most important research in modern science and nanotechnology and it allow 
multi-disciplinary professionals including scientist, engineers, chemists and 
physicians to joint venture and investigate the molecular and cellular levels that will 
lead to the advancement in the life sciences and healthcare field. The major 
advantages offer by nanoparticles (NPs) are due to their unique size and great 
physicochemical properties (Akbarzadeh et al., 2012). In the recent years, the 
advancement in nanoparticle research has impacted and benefited multiple industries 
by taking advantage of their special qualities of small “atomic-sized”. The unique 
properties may affect the immune system and human health in such a way that 
differs from those seen with larger particulates or gases (Chang, 2010). 
 
NPs share a quite similar size range as ultrafine particles, however the distinction 
between these two lies in their origin. The ultrafine particles refer the particles that 
are produced and released as an emissions result from industrial byproducts or 
everyday life, whereas NPs are engineered for specific purposes. NPs defined as 
particles with a diameter size of less than 100 nm  (Hardy et al., 2012; Hardy et al., 
2013) and the particles can be classified into three categories; naturally occurring 
NPs (e.g. volcanic eruptions or viral infection), anthropogenic NPs which produced 
inadvertently from human activity (e.g. combustion from vehicles engine, power 
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plants byproducts and incinerators) and engineered NPs produced for various 
industrial products (Chang, 2010; Mohamud et al., 2013). 
 
NPs have been utilized in various disciplines such as cosmetics, pharmaceutical 
application (Coester et al., 2006), DNA fingerprinting system (Choi et al., 2008), 
involve in the development of drug deliveries (Bender et al., 1996; Broos et al., 
2010; Chan et al., 2010; des Rieux et al., 2006) and diagnostics to detect biomarkers 
of heart disease, cancer theranostics (Gobbo et al., 2015; Hoang et al., 2015) and 
infectious agents (Akbarzadeh et al., 2012; Verma et al., 2013). 
 
1.3.2 Synthesis of nanoparticles 
 
The experimental silica colloid (SiO2) NPs and iron oxide (Fe3O4) NPs used 
in this study were synthesised via the so-called ‘Stöber process’ and ‘co-
precipitation’ methods. Stöber process is regarded as the simplest and most effective 
technique to prepare monodisperse silica particles since the reactants used are 
normal and the reaction process is controllable, low-cost and easy to be carried out 
(Wang et al., 2010). The preparation of monodisperse SiO2 NPs generally started 
with the hydrolysis and condensation of alkoxysilanes or tetraethylorthosilicate 
(TEOS) in a mixture of alcohol, water and ammonia which act as a catalyst for the 
whole reaction. This ammonia-catalyzed reaction of TEOS with water in low 
molecular weight of alcohols is famous for the production of monodisperse silica 
particles in spherical morphology (Nozawa et al., 2005) with size range of 0.05 to 2 
µm (Stöber et al., 1968).  
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Generally, the hydrolysis reaction gives the hydrolysed TEOS monomer 
[(OR)3Si(OH)] 
Si(OR)4 + H2O  (OR)3Si(OH) + ROH 
The intermediate reaction product then condenses to form silica particles according 
to the below chemical equation 
(OR)3Si(OH) + H2O  SiO2   + 3ROH 
The chemical reaction is a simplification of the complex condensation process that 
leads to the formation of silica particles. 
 
On the other hand, there are various methods that can be adopted to prepare the 
Fe3O4 NPs incuding microemulsion, thermal decomposition and co-precipitation 
method (Mahdavi et al., 2013). However, the co-precipitation method was used in 
this study because of its low cost and convenient steps despite of its capability in 
producing fine, high-purity and stoichiometric particles (Chen et al., 2005). As its 
reaction name implied, the co-precipitation is conducted by simultaneous 
precipitation of ferrous (Fe
2+
) and ferric (Fe
3+
) salt mixtures with the addition of 
strong base, in this case NaOH was used. The Fe (OH)2 and Fe(OH)3 were formed 
by the hydroxylation of the ferrous and ferric ions under anaerobic conditions 
(Jolivet et al., 2004). After that, the formation of Fe3O4 NPs can be obtained by 
collecting the black precipitate via magnetic separation and the chemical equation 
for this reaction is as follows: 
Fe
3+ 
+ 3OH
-
  Fe(OH)3 
Fe(OH)3  FeOOH + H2O 
Fe
2+ 
+ 2OH
-
  Fe(OH)2 
2FeOOH + Fe(OH)2  Fe3O4   + 2H2O 
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The reaction occurs very fast and magnetite crystals can be seen as soon as the 
strong base is added into the salts mixture. The reaction should be oxygen free in 
order to prevent the oxidation of magnetite NPs (Fe3O4) to hematite NPs; ferric 
hydroxide (γ-Fe2O3) (Mahdavi et al., 2013). 
 
1.3.3 Advantages of nanoparticles in biomedicine 
 
The unique physicochemical properties of NPs have offer great opportunities 
for collaborations with biomedical research that involves particularly specialized 
living organisms and require thorough investigations by both material scientist and 
biomedical engineers. Despite many challenges that have to be faced when dealing 
with the NPs, a well-established concepts, theories and methods need to be 
comprehend properly to translate the exclusive properties of NPs into a useful and 
creative biomedical applications. 
 
The benefits of this new research avenue to human health and civilization is indeed 
immeasurable (Chang, 2010) and in the recent decades, there is a remarkable 
increased in the use of NPs in medical applications, and they are foreseen to be 
widely applied in medical uses. Recently, various types of NPs are used for 
biological practices, for example, silica NPs have been used in diagnosis and 
bioanalysis (Tian et al., 2007), cell imaging (Tsai et al., 2008) and gene or drug 
delivery (Lu et al., 2007; Slowing et al., 2007), gold NPs involve in the theranostics 
and plasmonic phototermal therapy (PPT), magnetic metal NPs (e.g. Fe3O4 NPs) 
being used for magnetic resonance imaging (MRI) and hyperthermia therapy, 
quantum dots offer visibility alternative to positron emission tomography (PET) 
20 
 
imaging, plasmonic NPs enhance the surface plasmon and facilitate the naked eye 
readout (Giner-Casares et al., 2016) and organic NPs conjugated with DNA, protein 
or drug and acts as adjuvant in drug delivery activity. 
 
The uniqueness of NPs properties related with the nano-meter size particles that 
often range between 1 up to 100 nm and possess different physical and chemical 
composition compared to their bulk counterparts (Moghimi et al., 2005). The 
diminutive size of NPs facilitates their interaction or uptake by targeted cells, as well 
as enabling them to interfere with specific subcellular components which lead to a 
less toxic and more efficient therapeutic activity (Mohamud et al., 2013). By virtue 
of their tiny size and upon surface functionalisation with appropriate ligands and 
synthetic polymers, NPs can serve as drug carrier that target the specific cells and 
area inside human body after being injected intravenously or subcutaneously (Allen 
and Cullis, 2004; Krämer et al., 2004; Moghimi et al., 2001). This in vivo approach 
will eventually enhance the detection sensitivity in medical imaging such as MRI, 
improve the efficiency of therapeutic activity and nevertheless, can also suppress the 
side effects caused by conventional drugs or treatments. 
 
The interaction between both NPs and biomedicine is making their way in the fast-
pace activity in the research and development area of interest, however it is also 
pertinent to consider the issues that associated with the so-called nanotoxicity and 
thorough understanding on the physical and chemical properties of each types of NPs 
on each cells types. For example, studies found that the local or systemic toxicity 
which associated with exposure to metal NPs would impact acute and chronic nano-
bio interactions at the locations where the NPs are being deposited (Lee et al., 2016; 
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Shao et al., 2014). Hence, the consideration on the nanotoxicity effect of NPs to the 
cells is required to ensure a proper therapeutic alternative is made while addressing 
the safety of the nanoparticulate systems to be consumed by human immune system. 
 
1.3.4 Silica colloid and iron oxide nanoparticles 
 
The emergence of NPs role in biomedical application including the NPs-
mediated targeted drug delivery system have caused a great effect that lead to the 
development of new therapeutic and diagnostic tools (Liu et al., 2007). The research 
on this aspect has expanded tremendously in the recent years and there are various 
products available in the market, for example natural NPs like liposomes, 
dendrimers, and microbubbles and engineered nanovehicles such as silica NPs (Liu 
et al., 2006; Moghimi et al., 2005) and magnetic NPs (Chertok et al., 2010). 
Nanomaterials are capable to interact with biological system at molecular level with 
high specificity because of what we called as nano-effect (Jiang and Papoutsakis, 
2013; Silva, 2006). 
 
Silica is a versatile natural material component made up from sand and glass element 
that has been employed in engineering and material sciences for years. It has 
received spotlight for biomedical purposes due to its properties of being relatively 
benign material with no toxicity and good biocompatibility (Liu et al., 2007). The 
nano-effect can be successfully done with a proper understanding on the NPs size, 
surface properties and physicochemical properties. The silica NPs possess the unique 
features including tunable sizes and morphology, uniformly arranged particles, high 
surface area-to-volume ratio (Sahoo et al., 2014), high chemical stability than other 
22 
 
polymer-based NPs, the functional inner and outer surface of the particle which 
allow selective functionalisation, unique porous structure that is required to prevent 
premature release in drug delivery system and good in vivo biocompatibility (Asefa 
and Tao, 2012; Giret et al., 2015) and hemocompatibility (Slowing et al., 2009).The 
advantages of silica NPs were not only in industrial applications (e.g. acts as 
catalysts, pigments, fillers) but also in the scientific field that involve medicinal 
practice, for example, as a delivery system for cancer therapy (Lu et al., 2007), as a 
multifunctional probe for cell imaging (Tsai et al., 2008) and encapsulated magnetic 
NPs to be used in the diagnosis and therapy, as well as cell imaging (Chen et al., 
2010; Deng et al., 2008). 
 
Other than silica particles, hybrid nanostructures have also gained interest in the 
nanomedicine field because of their diverse physicochemical properties (Narayanan 
et al., 2011). Magnetic NPs belong to the group of hybrid nanostructures that have 
been explored for variety of biomedical applications due to their unique mesoscopic 
chemical, physical, mechanical and thermal properties (Mahdavi et al., 2013). Fe3O4 
NPs is one of the magnetic NPs which happen to be non-toxic, biocompatible (with 
special surface coating) and can be purposely modified with drugs, proteins, 
antibodies, nucleotides or enzymes to adjust the surface chemistry of the NPs for 
better biological performance. Based on the uniqueness of magnetic NPs, they have 
been widely studied and applied as MRI contrast agents (Lee et al., 2010; Mahdavi 
et al., 2013; Narayanan et al., 2011), induction of local hyperthermia towards an 
alternating magnetic field for cancer cells removal (Bae et al., 2012; Mahdavi et al., 
2013), and for magnetically targeted drug delivery system (Talelli et al., 2009).  
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1.3.5 Cellular uptake of nanoparticles 
 
Recently, the use of engineered NPs in various technological applications 
have undergo tremendous amount of investigations. Regardless of many studies that 
have been conducted to determine the toxicity of certain types of NPs on cells, 
however there is very little information on the uptake mechanism of NPs (Kettler et 
al., 2014). The knowledge of cellular uptake of NPs is crucial to evaluate the 
possible risk assessment of the NPs, to determine the functional behaviour of NPs 
according to their unique physicochemical properties and to improve the beneficial 
effects of NPs in biological applications (Kettler et al., 2014; Patil et al., 2007). 
 
The diminutive size of NPs ease the penetration of NPs into the cellular barriers and 
understanding on the uptake of mechanism of NPs into cells should be kept in mind. 
A cell membrane of cell is a physical barrier to separate the external environment 
and the internal cellular compartment of cells and particles with sizes of 10 nm to 30 
nm can easily cross the membrane (Lead and Smith, 2009). Hence, an endocytosis 
mechanism is a general type of uptake mechanism that works in overcoming this 
cellular barrier in its own specialized way. Endocytosis refers to the uptake of 
particulate substance (e.g. proteins) into the cells through the enclosure of cell 
membrane. Other than endocytosis, another uptake mechanism of NPs called as 
phagocytosis and pinocytosis are the internalization of particulate substances and 
small solute and the internalization of large amounts of solute, respectively (Mercer 
and Helenius, 2009). The pinocytosis mechanism can be divided into 
macropinocytosis (Kannan et al., 2004) and receptor-mediated endocytosis 
(Chithrani and Chan, 2007). 
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Apart from the specific uptake mechanism that can be demonstrated by the NPs to 
get into the cellular compartment, the surface chemistry of the NPs itself can 
ascertain the protein corona and contribute to a significant impact on the biological 
performance of the NPs internalization by the cells (Lundqvist et al., 2008; Patil et 
al., 2007). The properties of NPs that influence their uptake by cells are the size of 
NPs (Foged et al., 2005; He et al., 2010; Rejman et al., 2004; Win and Feng, 2005), 
surface charge of NPs (Foged et al., 2005; He et al., 2010; Patil et al., 2007), the 
functional group of NPs (Alexis et al., 2008) and the hydropholicity of NPs (Clift et 
al., 2008).  
 
The consideration and understanding on the uptake mechanism of NPs should be 
properly comprehends while constructing the nanomaterials as to ensure the 
functionality and biocompatibility of NPs with the cells go hand in hand. 
  
